Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron vs dexmedetomidine for reduction of postoperative nausea and vomiting
IRCT20101211005362N27Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron and dexmedetomidine in postoperative nausea and vomiting (PONV), sponsored by Isfahan University of Medical Sciences. Started Nov 2021; status: completed.
02
Drugs
ondansetrondexmedetomidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20101211005362N27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101211005362N27.